Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Geriatric Assessment × Genitourinary × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 3 Head & Neck 1 Gynecologic 1 Genitourinary 1

Conditions

Prostatic Neoplasms 3 Urinary Bladder Neoplasms 1 Prostate Cancer Cured 1 Neoplasms 1 Kidney Neoplasms 1 Frailty 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1 Breast Neoplasms 1

Interventions

pembrolizumab 21 Docetaxel 19 Gemcitabine 13 Paclitaxel 12 Nivolumab 11 pazopanib 10 Radiotherapy 9 Prednisone 9 Sorafenib 8 Therapeutics 7 Leuprolide 7 Ipilimumab 7 Cyclophosphamide 7 Carboplatin 7 Bevacizumab 7 avelumab 6 Thalidomide 6 Sunitinib 6 Cetuximab 6 Blood Specimen Collection 6 Axitinib 6 atezolizumab 5 Standard of Care 5 Radiosurgery 5 Radiation 5 Interleukin-2 5 Denosumab 5 temsirolimus 4 bicalutamide 4 Psychiatric Rehabilitation 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01776138 2021-10-06

PORCH

UNC Lineberger Comprehensive Cancer Center

Urinary Bladder Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡